ChargePoint (NYSE:CHPT) is showing stronger progress toward profitability after a better-than-expected second quarter, prompting UBS to raise its price target to $9 from $8 while maintaining a “neutral” rating. The bank lifted its fiscal 2027, 2028 and 2029 revenue forecasts following second-quarter sales of $116 million, which topped both consensus and UBS estimates, while adjusted EBITDA losses were significantly narrower than expected.



